Skip to main content
. 2022 Feb 28;57(4):267–285. doi: 10.1007/s00535-022-01861-z

Fig. 11.

Fig. 11

Comparison of the non-healing rate of severe reflux esophagitis between vonoprazan (VPZ) at 20 mg once daily for 8 weeks and lansoprazole (LPZ) at 30 mg once daily for 8 weeks by a meta-analysis limited to two domestic studies